I reperfusion injury after pig liver transplantation

Reperfusion injury is a serious problem after clinical liver transplantation, often leading to dys- or even non-function of grafts. The present study was designed to determine whether the hydrophilic bile salt tauroursodeoxycholate (TUDC), known to be hepatopro- tective in cholestatic liver disease, mitigates reperfusion injury in an in vivo pig liver transplantation model. Liver transplantation was perform- ed in 12 pigs after a preservation time of 8 h. TUDC was adminis- tered to donor and recipient ani- mals, and saline to controls. Blood was drawn at different time points for determination of liver enzymes. Bile samples were collected, and bile flow (BF), and bile salt secre- tion rate (BSSR) determined. Sam- ples of liver tissue and bile ducts were taken for assessment by light and electron microscopy. Liver en- zymes were significantly lower in the TUDC group. BF and BSSR were significantly higher. Microsco- py revealed better preservation of bile duct architecture of the TUDC- infused animals. We can conclude that infusions of TUDC in pig livers ameliorate reperfusion injury in vivo. The molecular basis for this finding may be the membrane stabi- lizing effect of TUDC. Further studies are warranted to clarify its effect.

[1]  C. Broelsch,et al.  Donor pretreatment with hydrophilic bile salts protects the liver from preservation and reperfusion injury in the rat. , 1997, Transplantation proceedings.

[2]  C. Broelsch,et al.  Infusion of hydrophilic bile salts protects the liver from reperfusion injury in the rat. , 1997, Transplantation proceedings.

[3]  T. Howard,et al.  Changes in liver core temperature during preservation and rewarming in human and porcine liver allografts. , 1996, Liver transplantation and surgery : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[4]  H. Bismuth,et al.  Risk factors of preservation injury and prognostic value of reperfusion biopsy in outcome of liver transplantation. , 1996, Transplantation Proceedings.

[5]  T. Howard,et al.  Evidence of preservation injury to bile ducts by bile salts in the pig and its prevention by infusions of hydrophilic bile salts , 1995, Hepatology.

[6]  G. Alexander,et al.  Serum alpha-glutathione S-transferase--a sensitive marker of hepatocellular damage associated with acute liver allograft rejection. , 1994, Transplantation.

[7]  T. Howard,et al.  Selecting the donor liver: Risk factors for poor function after orthotopic liver transplantation , 1994, Hepatology.

[8]  D. Heuman,et al.  Hepatoprotective properties of ursodeoxycholic acid. , 1993, Gastroenterology.

[9]  Y. Chrétien,et al.  Serum bile acids in primary biliary cirrhosis: Effect of ursodeoxycholic acid therapy , 1993, Hepatology.

[10]  U. Spengler,et al.  Effect of ursodeoxycholic acid on the kinetics of the major hydrophobic bile acids in health and in chronic cholestatic liver disease , 1992, Hepatology.

[11]  S. Bona,et al.  Liver ischemia for hepatic resection: where is the limit? , 1992, Surgery.

[12]  W. Pandak,et al.  Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts: In vitro studies in rat hepatocytes and human erythrocytes , 1991, Hepatology.

[13]  T. Starzl,et al.  EFFECT OF COLD ISCHEMIA TIME ON THE EARLY OUTCOME OF HUMAN HEPATIC ALLOGRAFTS PRESERVED WITH UW SOLUTION , 1991, Transplantation.

[14]  K. Boudjema,et al.  The effects of fasting on the quality of liver preservation by simple cold storage. , 1990, Transplantation.

[15]  P. Galle,et al.  Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes , 1990, Hepatology.

[16]  K. Dohi,et al.  Reliable indices for the determination of viability of grafted liver immediately after orthotopic transplantation. Bile flow rate and cellular adenosine triphosphate level. , 1988, Transplantation.

[17]  N. Jamieson,et al.  An analysis of the components in UW solution using the isolated perfused rabbit liver. , 1988, Transplantation.

[18]  F. Hanefeld,et al.  TREATMENT WITH URSODEOXYCHOLIC ACID RENDERS CHILDREN WITH BILIARY ATRESIA SUITABLE FOR LIVER TRANSPLANTATION , 1987, The Lancet.

[19]  T. Ueno,et al.  Morphological observation on extrahepatic bile duct of golden hamsters fed a lithogenic diet: histochemical, ultrastructural and cell kinetic studies. , 1994, Digestion.

[20]  J. Cofer,et al.  The influence of preservation injury on rejection in the hepatic transplant recipient. , 1990, Transplantation.

[21]  R. Superina,et al.  Donor-specific factors predict graft function following liver transplantation. , 1990, Transplantation proceedings.

[22]  S. Bellentani,et al.  Effect of ursodeoxycholic acid treatment on alanine aminotransferase and gamma-glutamyltranspeptidase serum levels in patients with hypertransaminasemia. Results from a double-blind controlled trial. , 1989, Journal of hepatology.

[23]  M. Nakahara,et al.  Correlation between cellular ATP level and bile excretion in the rat liver. , 1985, Transplantation.

[24]  M. Tansy,et al.  A demonstration of microvilli on the luminal surfaces of epithelial cells of the canine extrahepatic biliary tract. , 1975, Surgery, gynecology & obstetrics.